Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
J Antimicrob Chemother
.
2016 Jun;71(6):1747.
doi: 10.1093/jac/dkw079.
Epub 2016 Mar 8.
Authors
Oliver A Cornely
,
Rafael F Duarte
,
Shariq Haider
,
Pranatharthi Chandrasekar
,
David Helfgott
,
Javier López Jiménez
,
Anna Candoni
,
Issam Raad
,
Michel Laverdiere
,
Amelia Langston
,
Nicholas Kartsonis
,
Marlou Van Iersel
,
Nancy Connelly
,
Hetty Waskin
PMID:
26960721
PMCID:
PMC7297299
DOI:
10.1093/jac/dkw079
No abstract available
Publication types
Published Erratum